Financials
Income statement
Fiscal date | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
---|---|---|---|---|
Total reported revenue | 0 | 0 | 0 | 0 |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | 966K | 3.5M | 5.9M | 10.0M |
Selling general and admin | 2.5M | 3.1M | 2.7M | 3.0M |
Other operating expenses | -376K | -579K | -653K | -406K |
Operating income | -3.1M | -6.1M | -8.0M | -12.6M |
Non operating interest income | ||||
Income | 0 | 10K | 12K | 36K |
Expense | 23K | 23K | 19K | 42K |
Other income expense | 4.9M | 3.4M | 2.6M | 23.1M |
Pretax income | 1.7M | -2.7M | -5.5M | 10.5M |
Tax provision | — | — | — | — |
Net income | 1.7M | -2.7M | -5.5M | 10.5M |
Basic EPS | 0.7 | -1.6 | — | 19.2 |
Diluted EPS | 0.1 | -1.6 | — | -28.8 |
Basic average shares | 2.5M | 1.6M | — | 563.9K |
Diluted average shares | 2.5M | 1.6M | — | 617.2K |
EBITDA | -3.1M | -6.0M | -8.0M | -12.6M |
Net income from continuing op. | 1.7M | -2.7M | -5.5M | 10.5M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |